Upgrade to see committee overlap, performance context, and full expert analysis.
ARES congressional trades
8 matched disclosures
ARES congressional trades snapshot
This page summarizes public STOCK Act disclosures involving ARES. It is useful for seeing which lawmakers reported ARES transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.
Apr 14, 2026
Public House and Senate STOCK Act disclosures normalized by Congressional Trader.
Filing date can trail transaction date. This page is for research and monitoring, not investment advice.
What the ARES congressional trade page shows
Congressional Trader tracks 8 public STOCK Act disclosures for ARESacross 4 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.
The most recent ARES filing shown here was filed on Apr 14, 2026 by John Boozman as a purchase. Related lawmakers include Jefferson Shreve, Ritchie Torres, Val T. Hoyle, John Boozman.
Top lawmakers for ARES
Pro performance summary
Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.
Compare Pro plansUpgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
FAQ
Which lawmakers traded ARES?
Recent ARES disclosures include Jefferson Shreve, Ritchie Torres, Val T. Hoyle, John Boozman.
What is the buy/sell mix for ARES?
The visible sample currently shows 4 purchases and 4 sales or partial sales.
Should I trade based on ARES disclosures?
No. This page summarizes public filings for research and monitoring. It is not investment advice.